Sign in

CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company

BioXcel Therapeutics, Inc.

Sign in to watch
Ticker
BTAIQ
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821386754
Phone
203-643-8060
Business address
555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Planned sale Director sold 60,000 shares at $17.32 ($1,039,200)
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 4 Open-market sale CEO and President sold 64,500 shares at an average $18.97 ($1,223,313)
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 4 Open-market sale Chief Financial Officer sold 2,084 shares at $19.50 ($40,638)

Page 18 of 34 · 672 filings